Custom treatment improves overcorrection, night vision
October 1st 2004An off-label use of the CustomCornea procedure (Alcon Laboratories) to re-treat symptomatic eyes of patients who had undergone a previous refractive procedure produces dramatic reductions in visual symptoms, according to James J. Salz, MD.
Negative spherical aberration after CK is desirable
October 1st 2004San Diego-Inducing negative spherical aberration may be desirable after conductive keratoplasty (CK). Results of a study showed that patients with negative spherical aberration after CK met the target refractive error and target vision compared with patients with positive spherical aberration, according to Stephen Pascucci, MD, at the annual meeting of the American Society of Cataract and Refractive Surgery.
Alcon symposium draws 300 to hear ReSTOR, AquaLase experiences
September 19th 2004Emerging lens extraction and implantation technologies have worldwide appeal among ophthalmologists, and at the European Society of Cataract and Refractive Surgeons meeting, it was evident at an evening symposium conducted by Alcon Laboratories.
New surface ablation approach shows advantages over PRK
September 19th 2004Advanced surface ablation using the MEL 80 laser (ASA80, Carl Zeiss Meditec) showed significant advantages compared with conventional PRK, especially for the recovery of best-corrected visual acuity (BCVA), pain, and haze formation.
Botulinum toxin offers favorable results for diplopia after cataract, refractive surgery
September 19th 2004Investigators at the University of Florence, Florence, Italy, used injections of botulinum toxin into the appropriate muscles of patients who developed diplopia after cataract extraction or refractive surgery and retrospectively evaluated the results.
Inserts using femtosecond laser less traumatic, more accurate than conventional method
September 19th 2004The IntraLase femtosecond laser (IntraLase) allows less traumatic implantation of micro-thin prescription inserts (Intacs, Addition Technology) compared with the conventional mechanical method of implantation.
Accumulating scientific data supports MICS advantages, dispels concerns
September 19th 2004-Available scientific information provides ample evidence that bimanual microincision cataract surgery (MICS) is safe and effective, but further study is needed to show whether it is better than the coaxial approach, said Randall J. Olson, MD.
Binkhorst Lecture: Are phakic IOLs the wave of the future?
September 19th 2004Lucio Buratto, MD, of Milan, Italy, was the 2004 recipient of the Binkhorst Medal. In his address to the European Society of Cataract and Refractive Surgeons, Dr. Buratto reviewed the history of phakic IOLs, the major designs, their indications, visual outcomes, and associated complications.
Panel debates latest issues involving refractive surgery
September 18th 2004Lively and active discussion among some of the world's best refractive surgeons was the flavor of a refractive surgery panel discussion, held Sunday night following the day's sessions at the European Society of Cataract and Refractive Surgeons meeting.
Bausch & Lomb offers upgrades for Zyoptix and Millennium systems
September 18th 2004Bausch & Lomb has upgraded its Zyoptix 100 laser system by enhancing the safety and accuracy of the unit by introducing iris-recognition technology. The company also introduced an Advanced Flow System for its Millennium microsurgical system.
NuLens presents a new concept for an accommodating IOL
September 18th 2004With some of the leading ophthalmic surgeons and researchers from Europe and the United States in attendance, NuLens Ltd. introduced a new concept of accommodative IOLs for the treatment of presbyopia during an off-site presentation at the European Society of Cataract and Refractive Surgeons meeting.
IOL effective in reducing spherical aberration, no improvement in CFS
September 18th 2004The Tecnis Z9000 IOL (AMO) is effective in reducing spherical aberration following cataract surgery, but no improvement in contrast sensitivity function (CSF) was found related to this spherical aberration reduction, according to Gonzalo Munoz, MD, of Alicante, Spain.
Liquefaction device's multi-directional capabilities appear safe, effective
September 18th 2004Richard Tipperman, MD, presented how the multidirectional features of the AquaLase technology on the Infiniti phacoemulsification system (Alcon Laboratories) allow for an improved approach to cataract surgery.
Wavefront-guided outcomes satisfactory for hyperopia or mixed astigmatism
September 18th 2004The U.S. Multicenter Trials of wavefront-guided treatment of hyperopia and mixed astigmatism with the CustomView Ablation System (VISX) indicated that 9 months after treatment both groups had similar good results and patients expressed high levels of satisfaction with the outcomes.